Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05603481 · ClinicalTrials.gov registry record

CGM in Patients With ED's

A clinical trial of Avoidant Restrictive Food Intake Disorder and Anorexia Nervosa, Binge Eating/Purging Type, sponsored by Denver Health and Hospital Authority.

Completed
Registry status
50
Enrollment target
1
Study location

NCT05603481 is a study of Avoidant Restrictive Food Intake Disorder and Anorexia Nervosa, Binge Eating/Purging Type that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05603481, a study of Avoidant Restrictive Food Intake Disorder and Anorexia Nervosa, Binge Eating/Purging Type, has completed, sponsored by Denver Health and Hospital Authority.

COMPLETED
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anorexia nervosa, binge/purge subtype (AN-BP).

Interventions

  • DEVICE Continuous Glucose Monitor

Study Locations (1)

Colorado

  • Denver Health and Hospital Authority - Denver

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-05-09
Est. Completion 2024-07-02

What the Registry Record Tells You About NCT05603481

The ClinicalTrials.gov registry entry for NCT05603481 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Avoidant Restrictive Food Intake Disorder appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitor is the first listed.

NCT05603481 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05603481 about?

NCT05603481 is a clinical study titled "CGM in Patients With ED's". To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anore...

What is the current status of trial NCT05603481?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2023-05-09. Estimated completion is 2024-07-02.

What conditions does trial NCT05603481 study?

This clinical trial studies the following conditions: Avoidant Restrictive Food Intake Disorder, Anorexia Nervosa, Binge Eating/Purging Type, Anorexia Nervosa, Restricting Type, ARFID.

What interventions are being tested in trial NCT05603481?

The interventions under investigation include: Continuous Glucose Monitor (DEVICE).

Who is sponsoring clinical trial NCT05603481?

This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05603481 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Avoidant Restrictive Food Intake Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.